To Compare the Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability Between SHR-3167 Injection and Glargine Insulin in Healthy Subjects
Clinical trial NCT07588906 · COMPLETED
Trial details
- NCT number
- NCT07588906
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-26
- Primary completion
- 2024-07-12
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.